What Will Vaccine Liability Waivers Mean For The Covid-19 Inoculation

What Will Vaccine Liability Waivers Mean For The Covid-19 Inoculation. There will be issues with the new Coronavirus/Covid-19 vaccine because there were issues with every single vaccine introduced before. There are currently numerous studies and trials devoted to finding a shot that will give immunity to the recipient against the deadly and contagious Coronavirus/Covid-19 pandemic. The company that is first to introduce a successful shot for immunity will reap big rewards in the form of profits and scientific prestige. But when there are problems with it, as there certainly will be, what recourse does the public have?

Vaccine Liability Photo
Vaccine waivers protect manufacturers from lawsuits and liability other drugs have.

On his regular podcast, respected neurologist Dr. Steven Goldstein describes the risks and benefits of vaccines and a regulation known as the ‘vaccine liability waiver.’ The Houston Healthcare Initiative Podcast can be heard on SoundCloud, LibSyn, Google Play, iHeartRadio, iTunes, Stitcher, Radio.com and many other places where podcasts are heard.

What Is The Vaccine Liability Waiver?

According to Dr. Goldstein, vaccine liability waivers are really what the name implies which is that vaccine makers are not generally held responsible for injuries their vaccines may cause. “This is notable because it is the only part of the healthcare industry where such protection exists,” Dr. Goldstein told his listeners. “The companies that make these vaccines cannot be sued for monetary damages unless a person who died or was seriously injured can demonstrate that the company engaged in “willful misconduct” which is a very high legal standard to achieve.”

The Vaccine Waiver Makes Vaccines Possible

What Will Vaccine Liability Waivers Mean For The Covid-19 Inoculation? It is very likely that were it not for the ‘waiver’ there would be few if any vaccine makers in the U.S. Starting with the Salk vaccine in the 1950’s through the 1970’s and ‘80’s, lawsuits against vaccine makers increased to the point that there was only one Diphtheria Pertussis Tetanus (DPT) vaccine maker in the U.S.

In 1986 the U.S. Congress responded to the situation in the vaccine market by passing the ‘National Childhood Vaccine Injury Act’ or NCVIA. The act included a number of regulations related to informed consent and adverse event reporting but also removed many of the monetary recovery options that were putting the industry out of business.

Complexity Comes With Safeguards

Vaccines are developed, tested, and regulated the same as other drugs but more so. Vaccine development is a complex process that takes usually takes years. That is because the number of people in vaccine clinical trials are usually greater, and, those who receive vaccines are more in number than those who receive or take other prescription drugs. In addition, post-license monitoring of vaccines is closely examined by the Centers for Disease Control (CDC) and the Food & Drug Administration (FDA).

So, while the liability waiver exists, all the other pharmaceutical safeguards are in place. Regardless of expectations, no medical treatment is completely risk free. “Vaccines are made to protect us from disease, but they can have negative side effects,” Dr. Goldstein said. “Most of these effects are pretty mild like soreness in the arm from the injection. Others can be more serious. But without these rules it is unlikely anyone in the U.S. would be researching a Covid-19 vaccine.”

What Will Vaccine Liability Waivers Mean For The Covid-19 Inoculation? Nothing in the world of medicine is without risk and the ultimate introduction of the Coronavirus vaccine is no exception. The laws and regulations strike a balance that protects the public and aids in the delivery of a vaccine sooner than later.

The Effectiveness Standard for Covid-19

The minimum requirement by the Food and Drug Administration (FDA) for any COVID-19 vaccine is that it should at least prove 50% effective when compared with a placebo — that is, a neutral saline solution. The annual flu vaccine is a success when it is 40% – 60% effective. Fifty percent is right in the same range as the flu vaccine.

About The Houston Healthcare Initiative

Dr. Steven Goldstein is a Houston based neurologist. He founded the Houston Healthcare Initiative and is an advocate for common sense solutions to the healthcare crisis that confronts the citizens and residents of the United States of America.

 

Vaccine Development Liability Waivers Where Safety & Business Gel

The pluses and minuses of the vaccine liability waver laws on this edition of the Houston Healthcare Initiative Podcast.

Vaccine Development Liability Waivers Where Safety & Business Gel.

There are currently 120 Coronavirus/Covid-19 vaccines in development and a race to be the first one available for the public. Being first with this vaccine will mean big rewards for the maker in the form of profits and scientific prestige. Along with these developments there is political pressure to not only be first but be first by election day.

Regardless, the benefits of a vaccine for this extremely contagious virus will ultimately accrue to the public. But nothing is foolproof and there will be problems with this vaccine because there were with all of them. And when there are problems who is ultimately responsible and how can the public find justice? To know better what the possible risk benefit for a vaccine to the Covid-19 is and help us understand the possible downside and upside is respected Houston neurologist Dr. Steven Goldstein. On his podcast Dr. Goldstein describes the advantages of vaccine liability waivers and the potential downside.

Off Label Prescriptions Removed From The Table Overly Zealous Watchdogs Interfere with Patients and their Doctors

Off Label Prescriptions Removed From The Table….

Overly Zealous Watchdogs Interfere with Patients and their Doctors

October 1, 2020 – Does a physician or the pharmacist know what is best for a patient? When the Ohio

Off Label Prescriptions Removed From The Table….  Overly Zealous Watchdogs Interfere with Patients and their Doctors   October 1, 2020 – Does a physician or the pharmacist know what is best for a patient? When the Ohio Board of Pharmacy ruled that doctors could not prescribe the off-label treatment hydroxychloroquine to treat the Coronavirus/Covid-19 pandemic it was a chilling trespass into the rights of people in Ohio and set a dangerous precedent in the other forty nine.  Medicines to treat conditions with off-label prescribing occurs when a physician stipulates a drug that the U.S. Food and Drug Administration (FDA) has approved to treat a condition different than what a patient has. Off label prescribing is nothing new.   Unanticipated Consequences of Overly Aggressive Regulators This practice is legal and common as one in five prescriptions written today are for off-label use. The Ohio Board of Pharmacy decision was without precedent. Americans should be nervous about this instance because it puts the relationships between doctors and patients at risk and removes the judgement of physicians about how to best treat their patients, putting it into the hands of government regulators. “This overreach is a present and future danger for Americans and their doctors in the wake of the Coronavirus/Covid-19 pandemic,” Dr. Steven Goldstein told the audience on his podcast. “This puts decision making about how best to treat a patient into the hands of someone who does not know the individual, never mind has any medical experience with them.”  The Future Beyond Covid-19 The prospect that someone other than the doctor and patient are involved in this decision making is bad practice. “Doctors are trained and educated to diagnose and treat patients”, Dr. Goldstein said. “They also have experience treating their patients and know how to evaluate scientific papers about new treatments. Pharmacists and government bureaucrats do not have this training or experience.”   In the case of hydroxychloroquine there is no randomized controlled trial to prove scientifically whether or not this drug is effective for Covid-19. It is also true that there is no other treatment that has been proven with a randomized controlled trial to be effective. “Physicians should be able to use any treatment that may be beneficial to their patient,” Dr. Goldstein said. “Interference by government boards or other non-physicians will retard the development of effective treatments and lead to additional mortality and morbidity.” The next outbreak is a certainty, it’s only a matter of time. “If pharmacists and bureaucrats are getting between doctors and patients now, we should be very worried about the future,” Dr. Goldstein concluded.  About the Houston Healthcare Initiative Podcast The Houston Healthcare Initiative podcast with Dr. Steven Goldstein is an information vehicle for people who want to know all medical options for themselves and are interested in reforming the healthcare industry. To hear the podcast go to: SoundCloud, iHeartRadio, Stitcher, Backtracks, LibSyn, or the website at www.houstonhealthcareinitiative.org. Dr. Goldstein insists that for the health and welfare of the American public, the congress must pass reforms that limit the influence of the pharmaceutical industry and its lobby.
Overly Zealous Watchdogs Interfere with Patients and their Doctors.

Board of Pharmacy ruled that doctors could not prescribe the off-label treatment hydroxychloroquine to treat the Coronavirus/Covid-19 pandemic it was a chilling trespass into the rights of people in Ohio and set a dangerous precedent in the other forty nine.  Medicines to treat conditions with off-label prescribing occurs when a physician stipulates a drug that the U.S. Food and Drug Administration (FDA) has approved to treat a condition different than what a patient has. Off label prescribing is nothing new

Unanticipated Consequences of Overly Aggressive Regulators

This practice is legal and common as one in five prescriptions written today are for off-label use. The Ohio Board of Pharmacy decision was without precedent. Americans should be nervous about this instance because it puts the relationships between doctors and patients at risk and removes the judgement of physicians about how to best treat their patients, putting it into the hands of government regulators. “This overreach is a present and future danger for Americans and their doctors in the wake of the Coronavirus/Covid-19 pandemic,” Dr. Steven Goldstein told the audience on his podcast. “This puts decision making about how best to treat a patient into the hands of someone who does not know the individual, never mind has any medical experience with them.”

The Future Beyond Covid-19

The prospect that someone other than the doctor and patient are involved in this decision making is bad practice. “Doctors are trained and educated to diagnose and treat patients”, Dr. Goldstein said. “They also have experience treating their patients and know how to evaluate scientific papers about new treatments. Pharmacists and government bureaucrats do not have this training or experience.

In the case of hydroxychloroquine there is no randomized controlled trial to prove scientifically whether or not this drug is effective for Covid-19. It is also true that there is no other treatment that has been proven with a randomized controlled trial to be effective. “Physicians should be able to use any treatment that may be beneficial to their patient,” Dr. Goldstein said. “Interference by government boards or other non-physicians will retard the development of effective treatments and lead to additional mortality and morbidity.” The next outbreak is a certainty, it’s only a matter of time. “If pharmacists and bureaucrats are getting between doctors and patients now, we should be very worried about the future,” Dr. Goldstein concluded.

About the Houston Healthcare Initiative Podcast

The Houston Healthcare Initiative podcast with Dr. Steven Goldstein is an information vehicle for people who want to know all medical options for themselves and are interested in reforming the healthcare industry. To hear the podcast go to: SoundCloud, iHeartRadio, Stitcher, Backtracks, LibSyn, or the website at www.houstonhealthcareinitiative.org. Dr. Goldstein insists that for the health and welfare of the American public, the congress must pass reforms that limit the influence of the pharmaceutical industry and its lobby.

 

 

Federal Government Goofs Delayed Coronavirus Tests By 6-8 Weeks

The United States badly bungled coronavirus testing.
The United States badly bungled initial coronavirus testing. Federal Government Goofs Delayed Coronavirus Tests By 6-8 Weeks.

Federal Government Goofs Delayed Coronavirus Tests By 6-8 Weeks. On his regular podcast Dr. Steven Goldstein described how failures within the federal government delayed proper testing for the Coronavirus/Covid-19 virus by several weeks.  The outcome? Tracking and tracing the infection early in the process was impossible. The Houston Healthcare Initiative Podcast is available on SoundCloud, iHeartRadio,LibSyn, Spotify,  iTunes, Radio.com, Stitcher, ListenNotes, Podcast Addict, or the Houston Healthcare Initiative web site.

Early Kit Troubles

Early in the testing process the Food and Drug Administration (FDA) sent Coronavirus/Covid-19 test kits to approximately 100 health labs across the country. Initially the FDA had done all the testing in in-house, but more cases meant that tests had to be available in more locations. There was just one, very important mistake and that was there was no way to validate the tests and its ingredients all acted the same way when used, regardless of the location.

Thirty-six of the approximately 50 tests returned results to the FDA that were ‘inconclusive’. Manufacture of new ingredients for the tests took 3 weeks. The failure to get working test kits into public-health labs came at a really bad time. Early in any outbreak, contact tracing, isolation, and individual quarantines are used to contain the spread of disease. These steps don’t work when suspected cases cannot be tested. The gap made by the bad test kits made it impossible for public-health officials to get a read on how far and fast the disease was spreading. The result, Covid-19 spread undetected for several weeks. “The government was not prepared when it came to identifying and quarantining contacts of the first patients and preventing sick patients from entering the country,” Dr. Goldstein told his listeners. “Government bureaucracy delayed the development of laboratory tests for 6-8 weeks.”

Worse still, when an Emergency Use Application (EUA) test was sent via email and followed up with phone calls from the University of Washington Virology Lab to the FDA for approval, the applicants learned that U.S. law required a hard copy of the applications be sent with a CD or thumb drive via the U.S. Postal Service to be considered. Instead of using more advanced communications like e-mail the lab was forced to use ‘snail mail’. (The F.D.A. has since dropped the requirement to send a CD-rom or USB drive with a copy of the application).

Bureaucrats Want More Power Not Less

According to Dr. Goldstein, issues like this have more to do with the bureaucratic class maintaining its influence than protecting the public or any devotion to science. “People ensconced in government bureaucracy want to preserve their authority and it seems that they are willing to take drastic measures to preserve that power,” Dr. Goldstein said. “These people are very invested in expensive, high tech treatments. Low tech measures like contact tracing and quarantining and testing anyone entering the country could have controlled the epidemic early on.” One possible lesson from this is to remember that government takeover of any health crisis will persist long past any benefit is exhausted. Finding ways around these career government employees should be part of any proposed reform for the healthcare industry.

About the Houston Healthcare Initiative

Dr. Steven Goldstein is a Houston based neurologist. He founded the Houston Healthcare Initiative and is an advocate for common sense solutions to the healthcare crisis that confronts the citizens and residents of the United States of America. Federal Government Goofs Delayed Coronavirus Tests By 6-8 Weeks.

 

Best Selling Author Gerald Posner Discusses ‘Pharma: Greed Lies and Poisoning of America’

Gerald Posner on the podcast this week.
Gerald Posner latest work is “Pharma: Greed, Lies, and the Poisoning of America.” This book describes something we here are all very interest in which is the history of the pharmaceutical manufacturing industry.

In a special edition of the Houston Healthcare Initiative podcast best-selling author and investigative journalist Gerald Posner discusses the sordid history of the drug business from his most recent work, ‘Pharma: Greed Lies and the Poisoning of America.’ It reads like a ‘true crime’ novel, though everything in the volume is true. ‘Pharma: Greed Lies and the Poisoning of America’ is available at Amazon, just click here: ‘Pharma: Greed Lies and the Poisoning of America.’

The Houston Healthcare Initiative podcast can be heard on SoundCloud, iTunes, iHeartRadio, LibSyn, Spotify, and the Houston Healthcare Initiative web site. In the book and podcast Posner tells a compelling story that links the history of the pharmaceutical industry from the mid-19th century to the twenty first. It is not a flattering narrative. Many of the practices that were incorporated into marketing and selling heroin and cocaine in the early 20th century were and are still used today. And like they did before, the same companies are deliberately downplaying of the risk of modern-day medicines like opioids that have led to addiction and death for so many Americans.

Interests Intersect

Mr. Posner’s work and the interests of the Houston Healthcare Initiative coincide in several important ways. “The reform of the entire healthcare industry including the pharmaceutical business is our mission,” said Dr. Steven Goldstein who founded the Houston Healthcare Initiative. “We were very flattered he took time to talk with us and the audience about this important topic and we hope that everyone who reads his new book is inspired to act.”

Profits, Then Everything Else

Marketing, sales, advertising and abuse of patent law are all used against the American public to boost sales and stock prices of drug companies. This is part of the historic heritage that links the business’ past to today. “Only by knowing its history,” Mr. Posner writes, “is it possible to fully appreciate how the battle between noble ambitions and greed is a permanent conflict.” Mr. Posner tells many stories about the people behind the industry and the some of the ethically questionable things they did and still do.

Meet the Sacklers

The mindset of these and other actors id’ed in the book can be better understood with one of many informative stories Mr. Posner relates. According to Mr. Posner, eight people in a single family ‘made the choices that caused much of the opioid epidemic.’ The family in question is the Sacklers, notably Arthur, who “had some clever ideas of how to disguise product promotions as ‘news’ covered in consumer press.” According to media experts, the ad made to look like news or ‘advertorial’ is a really low rung on either the paid ad or public relations ladder.

Nazis? Really?

Mr. Posner detailed this during his interview on the podcast. “In 1947, defense attorneys for Nazi doctors charged with war crimes for human experimentation at concentration camps cited the malaria experiments in a failed effort for an acquittal. He went on, “when Nazi doctors are citing clinical trials from your industry as grounds for an acquittal in their own legal trials, you have erred.”

To learn more about Gerald Posner visit his web site at https://www.posner.com/.

About Houston Healthcare Initiative And Dr. Steven Goldstein

Dr. Steven Goldstein is a Houston based neurologist. He founded the Houston Healthcare Initiative and is an advocate for common sense solutions to the healthcare crisis that confronts the citizens and residents of the United States of America.

 

 

 

Possible Remedy for the Coronavirus/Covid-19 Global Pandemic Invites Immediate Controversy

Blood Plasma
Possible Remedy for the Coronavirus/Covid-19 Global Pandemic Invites Immediate Controversy
Treatment with blood plasma from recovered patients is an accepted practice that goes back to the early 20th century.

Possible Remedy for the Coronavirus/Covid-19 Global Pandemic Invites Immediate Controversy.

On August 23, 2020 the Food and Drug Administration (FDA) announced a decision to grant blood plasma treatment for Coronavirus/Covid-19 patients with a fast-track authorization for its emergency use as a treatment for hospitalized COVID-19 patients.

The next day, claims about the effectiveness of this treatment were retracted. Subsequent news coverage about this potential treatment did little to clarify blood plasmas’ usefulness or lack thereof. The idea that there could be a political motivation behind the fast track authorization for this potential treatment, other than looking for a useful therapeutic, is troubling.

Who Can Americans Believe?

On his regular ‘Houston Healthcare Initiative’ podcast, respected neurologist Dr. Steven Goldstein defines how this decision triggered an outcry from scientists and doctors, who said the decision was not supported by adequate clinical evidence and criticized the FDA for what was perceived as bowing to ‘political pressure’.

Dr. Goldstein also reviews those who believed this approach was worthwhile. Generally, treatment with blood plasma from recovered patients is an accepted practice that goes back to the early 20th century. Many believe the possibility that blood plasma from recovered Coronavirus/Covid-19 patients could help people fight off the virus was worthy of further investigation.

Who is correct? Who should the American public rely on for the best information about treatment for this global health emergency?

The Houston Healthcare Initiative podcast can be heard on: SoundCloud, Apple Podcasts, Stitcher, Listen Notes, iHeartRadio, and the Houston Healthcare Initiative web site.

About Houston Healthcare Initiative And Dr. Steven Goldstein

Dr. Steven Goldstein is a Houston based neurologist. He founded the Houston Healthcare Initiative and is an advocate for common sense solutions to the healthcare crisis that confronts the citizens and residents of the United States of America. Blood plasma treatment for Covid-19 patients invites controversy.

Blood Plasma Covid Treatment and Pharmaceutical Industry Reform

Blood plasma covid treatment and pharmaceutical industry reform. On August 23, 2020 the Food and Drug Administration’s announced a decision to grant blood plasma treatment for Coronavirus/Covid-19 patients with a  fast-track authorization for its emergency use as a treatment for hospitalized COVID patients. This “emergency use authorization” triggered an outcry from scientists and doctors, who said the decision was not supported by adequate clinical evidence and criticized the FDA for what was perceived as bowing to political pressure.

Should Pharma choose people over profit?
Big Pharma has a big influence on the congress from multi-million dollar lobbying effort.

News coverage about this potential treatment has done little to clarify whether its useful or not. The idea that there could be a motivation behind the fast track authorization for this potential treatment other than looking for a useful therapeutic is troubling. More to the point, who should decide what patients receive in treatment for their illnesses? To help us make sense of how reforms for the pharmaceutical industry could potentially help separate facts from spin and who we should all listen to is respected neurologist, Dr. Steven Goldstein. Click below to listen.

To read more about this issue please click below: https://www.sciencemag.org/news/2020/08/fda-s-green-light-treating-covid-19-plasma-critics-see-thin-evidence-and-politics.

A Retracted Article Drove Misunderstanding of Hydroxychloroquine

A Retracted Article Drove Misunderstanding Hydroxychloroquine

A Retracted Article Drove Misunderstanding of Hydroxychloroquine. No one can unring a bell. When articles published in the Lancet and the New England Journal of Medicine published and then retracted an article critical about the possible use of hydroxychloriquine as a treatment for Coronavirus/Covid-19 they may have shown good faith with the retractions but the damage was done. On his regular podcast, Dr. Steven Goldstein discusses how and why the use of an inexpensive drug was widely criticized. An article from Tablet magazine (Hydroxychloroquine: A Morality Tale) describes the issue in detail.

The criticisms were based on the retracted articles, but there was more to it. Political agendas and money both added to the manufactured confusion about a drug that was used to treat malaria, lupus and others without controversy. Dr. Goldstein believes that reforms for government and the pharmaceutical manufacturing industry were never more obvious than in this example. A Retracted Article Drove Misunderstanding of Hydroxychloroquine.

Was There Ever A Better Time To Reform Drug Prices?

US & Canadian Drug Prices

In the Coronavirus/Covid-19 Pandemic Age Come Ideas for Drug Price Reform

In the coronavirus/covid-19 pandemic age drug reform is topical.

According to Dr. Steven Goldstein on his podcast, “without meaningful modification, drug prices and pressure on patient’s ability to pay and manufacturers resources for discovery will reach a tipping point.” Dr. Steven Goldstein lists the reasons for the discrepancy and how the U.S. could reform the laws that govern the ways therapeutic medicine gets from the lab bench all the way to the patient for whom it is intended.

Some of these include:

  • Reform drug patent law. The patent system for drugs needs to be reformed so that drug development costs can be recouped along with a profit. Once this occurs, the patent should expire.
  • Streamline approval. The FDA needs reform so that drug authorizations are more efficient. Possibly, an international FDA funded by a consortium of countries could approve drugs.
  • Eliminate monetary incentives from drug companies for writing prescriptions.
  • Drug discounts to insurance companies and Medicare should be illegal.
  • Enforce the laws already passed. Antitrust laws for price collusion need to be enforced.

    US & Canadian Drug Prices
    In the coronavirus/covid-19 pandemic age drug reform is topical. For U.S. drug prices to be affordable and provide enough resources for continued research serious reform is needed. 

To hear Dr. Goldstein’s podcast listen on SoundCloud, iHeartRadio, iTunes, Stitcher, and the website at www.houstonhealthcareinitiative.org.

 

Why Are Prescription Drugs Cheaper in Canada?

Why Are Prescription Drugs Cheaper in Canada?

Even those with private, employer funded health insurance gasp at the price of some prescription medications. Learning that the same medicine is available north of the border at a substantially reduced price often produces other emotional reactions from surprise to anger. There are plenty of reasons those drugs are priced differently.

drug prices in Canada are lower because the Canadian government regulates the price.
Why Are Prescription Drugs Cheaper in Canada? Prices in Canada are lower because the Canadian government regulates the price.

Listeners to the Houston Healthcare Initiative podcast will learn why as respected neurologist Dr. Steven Goldstein explains how the combination of foreign government requirements and U.S. government non-regulation combined to give the American public sticker shock at the drug store.

The Houston Healthcare Initiative podcast can be heard on SoundCloud, iHeartRadio, iTunes, Stitcher, and the website at www.houstonhealthcareinitiative.org.

Canadian Government Declares Prices

In short, drug prices in Canada are lower because the Canadian government regulates the price. In Canada, a review board decides on pricing and what they believe are reasonable or excessive prices. If they decide a drug is priced too high, they will not allow it on the drug formulary. This board, the Patented Medicine Prices Review Board, is described in Canada as a quasi-judicial agency.

Before a prescription drug can be sold in Canada it is scientifically reviewed to make certain that it can do what it is supposed to do. A committee of experts known as the Human Drug Advisory Panel will make recommendations about other valid drugs on which to make comparison, in addition to recommendations for the categorization of new drugs. The level of therapeutic improvement of an existing patented drug is used to determine a ceiling price, known as the Maximum Average Potential Price, at its introduction.

U.S. Prices Set by Industry

The U.S. government is prohibited by law from negotiating prices for Medicare and other government programs. “Obviously, the drug company needs to recoup the cost of research, manufacture, advertising and the cost of getting the drug approved by the FDA,” Dr. Goldstein told his listeners. “The people in this country essentially pay for all of this work as countries like Canada do not allow their citizens to share the cost.” New drugs are issued a patent giving the drug company a monopoly on sale of the drug for 20 years. The drug company is free to set whatever price it likes for prescription drugs. Prices are then negotiated between insurance companies and the manufacturers.

Needed Drug Price Reforms

The U.S. and Canadian systems each present two very different models for drug pricing, neither of which is reasonable. The Canadian system does not allow enough incentive for new drugs to be created. The American system results in unaffordable prices. “There are several needed reforms,” Dr. Goldstein said. “We are not able to flip a switch and adopt the prices charged in Canada, though that would be nice.”

The reforms Dr. Goldstein recommends are:

  • Reform drug patent law. The patent system for drugs needs to be reformed so that drug development costs can be recouped along with a profit. Once this occurs, the patent should expire.
  • Streamline approval. The FDA needs reform so that drug authorizations are more efficient. Possibly, an international FDA funded by a consortium of countries could approve drugs.
  • Eliminate monetary incentives for writing prescriptions.
  • Drug discounts to insurance companies and Medicare should be illegal.
  • Enforce the laws already passed. Antitrust laws for price collusion need to be enforced.

“If these reforms were enacted, prices for drugs would be determined more by supply and demand,” Dr. Goldstein said. “This would ensure an adequate supply at the lowest price. For high priced drugs of marginal benefit, demand would be low and would tend to cause the price to drop. For new orphan drugs, the government could provide subsidies.”

About Houston Healthcare Initiative

Houston Healthcare Initiative (HHI) was founded by Dr. Steven Goldstein. Like many Americans, Dr. Goldstein is concerned about the state of the U.S healthcare system as well as the sorry state of the public’s health. The Houston Healthcare Initiative web site is an aggregator of news, healthcare pricing information, and resources for those who want to help drive reform for the healthcare industry. HHI’s emphasis for reform is on free market innovation and personal responsibility.